Natco Pharma has informed that it enclosed Annual Secretarial Compliance Report for the year ended March 31, 2021, as per Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with SEBI Circular No. CIR/CFD/CMDI/27/2019 dated February 8, 2019 for the year ended March 31, 2021.
The above information is a part of company’s filings submitted to BSE.